Akash Roy

Honoured and ecstatic @AASLDtweets @AASLDFoundation @RadhaKDhiman

24th #CuttackHepatitisSymposium to be organised on the eve of #WorldHepatitisDay at Mayfair Convention. Organised by @KGF_Trust and @AIIMSBhubaneswr Gastroenterology Dept. Key speakers include @wadhawan_manav @DrKaushalMadan1 @RoyAHep @PrajnaAnirvan @NancyReau #LiverTwitter

Join us for the 2nd edition of AIG Liver Conclave on 26th and 27th September at Hyderabad . @MajaThiele @gvraoaig @ebtapper @JasmohanBajaj @ArunJSanyalVCU @ProfPaoloAngeli @ajay_duseja @DrMarkMuthiah @KailashKolhe @RoyAHep @drnipunverma @INASL_Liver @VCU_Liver #liverx

🚨 Excited to share that my review article on MASLD pharmacotherapy is now published in the July 2025 issue of the Journal of the Association of Physicians of India (JAPI)! Here is a short thread 🧵 about it. japi.org/article/japi-7…

📑 #Atorvastatin for patients with cirrhosis: an RCT❕ 🔴 No change in mortality 🔴 No change in hospitalization 🟢 ⬇️ systemic inflammation! 🟢 Effects on lipidomics #LiverTwitter journals.lww.com/hepcomm/fullte…

Midodrine can reduce complications of LVP. ever indebted to my teachers @MaiwallRakhi @drshivsarin for guiding me on this study. link.springer.com/article/10.100… #liverx @RoyAHep @RohitMehtaniDM @ProfPaoloAngeli @LiverFellow

This Study clearly shows that GAAP model outperforms other models in detecting early-stage HCC. Comparison of GALAD, GAAP & ASAP Scores for HCC Detection in Patients with Chronic Liver Diseases - Journal of Clinical and Experimental Hepatology jcehepatology.com/article/S0973-…

Happy to Share the 2024 Journal Impact Factor, which is rising...... Thanks for being an integral part of this shared achievement. Your research and published content can help move us together towards a better future.

Can we⬇️avoidable #readmissions in #cirrhosis? Yes! A multi-center #RCT of #PatientBuddy & #EncephalApp @VCUHealth @MayoClinicGIHep & @RichmondVAMC 🙏@AHRQNews 🔑Diff practice types 🔑464 subjects (w caregivers) 🔑Freely available Apps @HEP_Journal ⤵️ journals.lww.com/hep/abstract/9…

Adoption of the New Nomenclature of MASLD by INASL - Implications on it's previous guidelines on NAFLD. Now available on PubMed pubmed.ncbi.nlm.nih.gov/40535844/ @AASLDtweets @AASLDPresident @EASLnews @EASLedu @marurinella @KanwalFasiha @AleksanderKrag @DebbieShawcros1 @JVLazarus

INASL-2025 Chandigarh - 7-10th August, 2025 Postgraduate Course on - Basics and Advances of Hepatology 8th August, 2025 Register Now- inasl2025.com @drsuniltaneja @docMPK @drnipunverma @doc_arka @naveendandia @drbabupgi @HepatologyPGI @EASLnews @EASLedu

Low versus High doses of steroids in AIH? ☑️ Similar rates of biochemical response with either ☑️Similar rates of further decompensation ☑️ Higher ADR with higher steroid doses ⚠️Predominantly cirrhotic population ⚠️ More data needed! doi.org/10.1007/s10620…

It's finally here! Consensus #ACLF & #cirrhosis organ failure definitions. @AGA_Gastro ⤵️ pubmed.ncbi.nlm.nih.gov/40499736/ Why? We need to speak the same language re #ACLF for #transplant/new Rx dev How? Multi-country consensus panels Result? Harmonized definitions &  research agenda

Global Fatty Liver Day!! “Fatty Liver is Preventable! Control Diabetes, Hypertension, Obesity, and Dyslipidemia.” Healthy Diet and Regular Exercise can do wonders !!! @INASL_Liver @ajay_duseja @docMPK @doc_arka @drnipunverma @SahajRathi @RohitMehtaniDM @RoyAHep @EASLnews

🫀 Your liver works silently, but tirelessly. 🥦 Eat healthy 💤 Sleep well 🏃‍♂️ Move daily ✅ Fatty liver is preventable - let’s act now! #LiverHealth #PreventFattyLiver #EatMoveSleep 😊🌿 @INASL_Liver

Globa Fatty Liver Day 2025 Physician awareness and engagement to tackle the ever expanding burden Excellent initiative @INASL_Liver @ajay_duseja

📷 New from PGI Chandigarh! 📷 #PankajGupta et al propose a simple non-contrast Abbreviated MRI (T2W, DWI) to categorize liver lesions in CLD—no contrast needed! 3 clear categories: Benign, Equivocal, Malignant 88% accuracy in real-world patients doi.org/10.1016/j.jceh…

Using Abb MRI for Liver Imaging Checkout the proposed Abb-MRI classification #pankajgupta @ajay_duseja @docMPK @drnipunverma @INASL_Liver @LiverFellow 👇🏽 jcehepatology.com/article/S0973-…

More data on the "Methotrexate Myth" Coming from the 🇮🇳DILI master #harshaddevarbhavi Look at co-morbidities before the judgment @INASL_Liver @LiverFellow @ebtapper @AnandVKulkarni2 @docMPK @ajay_duseja @theliverdr @drnipunverma jcehepatology.com/article/S0973-…

Important 🇮🇳 data coming from @AnandVKulkarni2 Much needed in the Wilson Spectrum

The Prince of MetALD shared his insights and they cannot be missed! 📊 PEth increasingly used to diagnose under-recognized ALD within MetALD 📏 Quantity of Alcohol, AUDIT-C, and DSM-V criteria can be used for MetALD assessment 🔍 Check out research gaps in this evolving field